AMY CLARK HESSEL to Oropharyngeal Neoplasms
This is a "connection" page, showing publications AMY CLARK HESSEL has written about Oropharyngeal Neoplasms.
Connection Strength
0.329
-
Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results. Clin Cancer Res. 2020 07 01; 26(13):3211-3219.
Score: 0.094
-
Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registry. Oral Oncol. 2019 04; 91:13-20.
Score: 0.087
-
Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma. Head Neck. 2018 11; 40(11):2507-2513.
Score: 0.084
-
Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer. 2014 Oct 01; 120(19):3082-8.
Score: 0.063